Sino BiologicalInc Future Growth
Future criteria checks 3/6
Sino BiologicalInc is forecast to grow earnings and revenue by 29.5% and 14% per annum respectively while EPS is expected to grow by 29.5% per annum.
Key information
29.5%
Earnings growth rate
29.5%
EPS growth rate
Biotechs earnings growth | 34.3% |
Revenue growth rate | 14.0% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 29 Apr 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2025 | 819 | 378 | N/A | 321 | 1 |
12/31/2024 | 721 | 331 | N/A | 297 | 2 |
3/31/2024 | 642 | 220 | -562 | 306 | N/A |
12/31/2023 | 646 | 260 | -721 | 323 | N/A |
9/30/2023 | 620 | 232 | -826 | 256 | N/A |
6/30/2023 | 568 | 246 | -840 | 263 | N/A |
3/31/2023 | 556 | 272 | -112 | 214 | N/A |
1/1/2023 | 575 | 303 | 93 | 249 | N/A |
9/30/2022 | 583 | 440 | 223 | 357 | N/A |
6/30/2022 | 630 | 470 | 271 | 368 | N/A |
3/31/2022 | 685 | 502 | 411 | 470 | N/A |
1/1/2022 | 965 | 720 | 595 | 643 | N/A |
9/30/2021 | 1,341 | 933 | 981 | 1,009 | N/A |
6/30/2021 | 1,736 | 1,236 | 1,317 | 1,338 | N/A |
3/31/2021 | 1,942 | 1,396 | 1,293 | 1,313 | N/A |
12/31/2020 | 1,596 | 1,128 | 1,075 | 1,093 | N/A |
12/31/2019 | 181 | 36 | 8 | 42 | N/A |
12/31/2018 | 139 | 36 | 10 | 37 | N/A |
12/31/2017 | 101 | 13 | N/A | 23 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 301047's forecast earnings growth (29.5% per year) is above the savings rate (2.9%).
Earnings vs Market: 301047's earnings (29.5% per year) are forecast to grow faster than the CN market (24.4% per year).
High Growth Earnings: 301047's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 301047's revenue (14% per year) is forecast to grow slower than the CN market (14.6% per year).
High Growth Revenue: 301047's revenue (14% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 301047's Return on Equity is forecast to be high in 3 years time